Drug Reference
Stavudine
Nucleoside and nucleotide reverse transcriptase inhibitors
Fact box
- Therapeutic class
- Nucleoside and nucleotide reverse transcriptase inhibitors
- Action class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- Mechanism
- Nucleoside Reverse Transcriptase Inhibitors
- Chemical class
- Nucleoside Analog
- Habit forming
- No
Available as
15 MG · Oral Capsule20 MG · Oral Capsule30 MG · Oral Capsule40 MG · Oral Capsule1 MG/ML · Oral Solution150 MG · Oral Tablet30 MG · Disintegrating Oral Tablet60 MG · Disintegrating Oral Tablet
No structured FDA label was available. Use the authoritative links below.
Current FDA labels (DailyMed)
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.